Recent advancements in Alzheimer’s research have unveiled a groundbreaking approach known as TIM-3 Alzheimer’s treatment, leveraging the interactions of the immune system with brain cells to combat disease progression.This innovative method involves targeting the TIM-3 checkpoint molecule, which has been shown to inhibit microglia from effectively clearing amyloid plaques associated with Alzheimer’s.